Insulin Analogs, Pen Delivery Devices Most Used Among Patients With T2D

October 18th 2021, 9:30pm


Using data from a nationally representative sample, investigators sought to determine trends in insulin device use.

Light Drinking Linked With Lower Risk of Type 2 Diabetes for Some Women

October 15th 2021, 6:21pm


Some alcohol, but not more than 1 drink per day, was linked to a 55% lower risk of type 2 diabetes in women with a history of gestational diabetes.

Study Finds Statin Use Associated With Diabetes Progression

October 11th 2021, 4:30pm


Using electronic medical record data from Veterans Affairs, researchers found statin use was associated with a greater risk of diabetes progression.

Patient and Supporter Factors Affecting Engagement With Diabetes Telehealth

October 8th 2021, 1:00pm


Family support with medication management and recent urgent self-management concerns are 2 novel factors, among others, that predict completion of diabetes telehealth calls.

Diabetic Nephropathy, Obesity Increase COVID-19 Mortality Risk in Patients With Type 2 Diabetes

October 4th 2021, 4:02pm


Patients with T2D had elevated blood glucose levels but there were no notable differences in levels between surviving and non-surviving patients with T2D.

Dr Deepak Bhatt on the Importance of In-Hospital Initiation of SGLT2 Inhibitors

September 29th 2021, 8:00pm


Deepak L. Bhatt, MD, MPH, outlines the benefits of starting patients on sodium glucose co-transporter 2 (SGLT2) inhibitors while they are hospitalized.

Medicaid Expansion Linked With Reduction in Uninsurance and Improved Blood Pressure, Glucose Control Measures

September 27th 2021, 3:00pm


Results of a representative study of patients at federally qualified health centers found Medicaid expansion was associated with reduced rates of uninsurance, improved blood pressure and diabetes control measures, and progress in closing racial care disparities over 5 years.

Managing the Surge: Delayed Chronic Wound Care During COVID-19

September 21st 2021, 1:00pm


Encourage Further SGLT2 Inhibitor Treatment for Diabetes, Kidney Disease, Expert Says

September 20th 2021, 2:23pm


New data from the CREDENCE trial shows that the sodium glucose co-transporter 2 (SGLT2) inhibitor canagliflozin may reduce hyperkalemia risk in people with type 2 diabetes and chronic kidney disease who are using RAAS inhibitors.

Presentation Outlines Long-term CV Risks of Gestational Diabetes

September 10th 2021, 9:00pm


A session at the 5th annual Heart in Diabetes Conference highlights the long-term risks of gestational diabetes.